{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-174459","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.210673+00:00","generated_at":"2026-05-17T19:54:32.223260+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cytek Q2 2025 revenue $45.6M (-2% YoY); narrows 2025 guidance to $196-205M","bullets":["Revenue $45.6M, down 2% YoY; net loss $5.6M vs $10.4M loss in Q2 2024.","Adjusted EBITDA $1.3M (down from $2.9M); operating loss $10.6M vs $8.5M.","Installed base grew to 3,295 instruments (146 new units); launched Aurora Evo system.","Recurring revenue up 16% YoY; repurchased $4.5M in stock during Q2.","2025 revenue guidance narrowed to $196-205M (flat to -2% growth over 2024)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-174459","json":"https://secwatch.observer/filing/0001193125-25-174459.json","markdown":"https://secwatch.observer/filing/0001193125-25-174459.md","text":"https://secwatch.observer/filing/0001193125-25-174459.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312525174459/0001193125-25-174459-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312525174459/d27070d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:54:32.223260+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}